Order of the President of the Court of First Instance of 31 October 2000 in Case T-76/00 R: Bruno Farmaceutici SpA v Commission of the European Communities (Proceedings for interim relief — Withdrawal of marketing authorisation for medicinal products for human use containing amfepramone — Directive 75/319/EEC — Urgency — Need to balance interests)
Date: 2001-04-07
Institutions: Court of First Instance
Subjects: European Commission, action for annulment (EU), medicinal product, pharmaceutical industry, withdrawal from the market

C 108/20

EN

Official Journal of the European Communities

7.4.2001

Hague, represented by E.H. Pijnacker Hordijk, of the Amster-
dam Bar, S.B. Noë, of the Hague Bar, and M.S.H. de Ranitz, of
the Amsterdam Bar, with an address for service in Luxembourg
at the Chambers of M. Loesch, 11 Rue Goethe, v Commission
of the European Communities (Agent: W. Wils) — application
for partial suspension of operation of
the Commission’s
decision 2000/117/EC of 26 October 1999 concerning a
proceeding pursuant to Article 81 of the EC Treaty (Case
IV/33.884 — Nederlandse Federatieve Vereniging voor de
Groothandel op Elektrotechnisch Gebied and Technische Unie
(FEG and TU)) (OJ 2000 L 39, p. 1) — the President of the
Court of First Instance made an order on 14 December 2000,
the operative part of which is as follows:

1.

2.

3.

CEF City Electrical Factors BV and CEF Holdings Ltd are
granted leave to intervene in support of the form of order sought
by the defendant in the proceedings for interim measures.

The application for interim measures is dismissed.

The costs are reserved.

ORDER OF THE COURT OF FIRST INSTANCE

of 19 October 2000

in Case T-58/00: Bond van de Fegarbel-Beroepsverenigin-
gen and Others v Commission of the European Communi-
ties (1)

(Action for annulment — Commission Regulation (EC)
No 2790/1999 — Inadmissibility)

(2001/C 108/36)

(Language of the case: Dutch)

In Case T-58/00: Bond van de Fegarbel-Beroepsverenigingen,
established in Brussels, Jules Appeltants, residing at Grâce-
Hollogne (Belgium), and Benny Corbeels, residing at Louvain
(Belgium), represented by J. Van Hoof, of the Brussels Bar, with
an address for service in Luxembourg at the Chambers of
F. Brouxel, 6 Rue Zithe, v Commission of the European
Communities (Agent: W. Wils) — application for annulment of
Commission Regulation (EC) No 2790/1999 of 22 December
1999 on the application of Article 81(3) of the Treaty to
categories of vertical agreements and concerted practices (OJ
1999 L 336, p. 21) — the Court of First Instance (Third
Chamber), composed of: J. Azizi, President, and K. Lenaerts
and M. Jaeger, Judges; H. Jung, Registrar, made an order on
19 October 2000, the operative part of which is as follows:

1.

2.

The action is dismissed as inadmissible;

The applicants are to pay the costs.

(1) OJ C 149 of 27.5.2000.

ORDER OF THE PRESIDENT OF THE COURT OF FIRST
INSTANCE

of 31 October 2000

in Case T-76/00 R: Bruno Farmaceutici SpA v Commission
of the European Communities

(Proceedings for interim relief — Withdrawal of marketing
authorisation for medicinal products for human use contain-
ing amfepramone — Directive 75/319/EEC — Urgency —
Need to balance interests)

(2001/C 108/37)

(Language of the case: German)

In Case T-76/00 R: Bruno Farmaceuti SpA, established in
Rome, Essential Nutrition Ltd, established in Brough (United
Kingdom), Hoechst Marion Roussel Ltd, established in
Uxbridge (United Kingdom), Hoechst Marion Roussel SA,
established in Brussels, Marion Merrell SA, established in
Puteaux (France), Marion Merrell SA, established in Barcelona
(Spain), Sanova Pharma GmbH, established in Vienna, Temm-
ler Pharma GmbH & Co. KG, established in Marburg (Germ-
any), represented by B. Sträter, Rechtsanwalt, Bonn, Germany,
with an address for service in Luxembourg at the Chambers of
Bonn and Schmidt, 7 Val Sainte-Croix, against the Commission
of
the European Communities (Agents: H. Støvlbæk and
B. Wägenbaur) — application for the suspension of application
of the decision of the Commission of 9 March 2000 concern-
ing the withdrawal of authorisations for placing on the market
medicinal products
for human consumption containing
amfepramone (C(2000) 453) — the President of the Court of
First
the
Instance made an order on 31 October 2000,
operative part of which is as follows:

1.

The application to the applicants of
the
Commission of 9 March 2000 concerning the withdrawal of
authorisations for placing on the market medicinal products for
human consumption containing amfepramone (C(2000) 453)
is suspended.

the decision of

2.

Costs are reserved.